AlphaBiolabs Health Testing Review: What GLP-1 Users Should Test

Starting a GLP-1 medication without baseline bloodwork is a bit like tracking a race without a starting line. You can see the direction of travel, but you have no idea how far you have actually come.

AlphaBiolabs is a UK-based testing laboratory with an established track record in DNA testing, drug testing, and more recently, health and wellness panels. For GLP-1 users, the question is straightforward: do their health testing options cover the markers that matter, and is the process straightforward enough to fit into a monitoring routine?

This review answers both of those questions. It also covers what GLP-1 users specifically need to test, when to test it, and how AlphaBiolabs fits into a broader monitoring protocol.

Why Testing Matters Before and During GLP-1 Treatment

GLP-1 receptor agonists (semaglutide as Ozempic and Wegovy, and tirzepatide as Mounjaro) affect multiple organ systems simultaneously. Weight loss is the visible outcome. Underneath that, liver fat, blood glucose, lipid profiles, kidney function, and thyroid markers are all shifting too.

The changes are mostly positive. But without baseline data, you cannot confirm they are happening in your case, and you cannot detect the minority of cases where something unexpected occurs: a kidney function dip from dehydration, a rise in liver enzymes, a lipid marker moving in the wrong direction.

For users paying privately for GLP-1 prescriptions, routine NHS monitoring is often limited. Private prescribers vary considerably in how much follow-up testing they include. That creates a gap, and filling it with at-home health testing is increasingly common practice.

What Is AlphaBiolabs?

AlphaBiolabs is a UK laboratory accredited by the United Kingdom Accreditation Service (UKAS). They are best known for paternity DNA testing and workplace drug testing, but they have expanded into consumer health and wellness testing, including blood panels and genetic health markers.

Their health testing division offers a range of at-home collection kits. Samples are returned by post and analysed at their UK-based laboratory. Results are delivered digitally, typically within a few days of the sample arriving at the lab.

They are not a prescriber or clinical service. If you need a GLP-1 prescription or clinical interpretation of results, you need to take findings to your GP or prescriber. AlphaBiolabs provides the data; clinical management sits elsewhere.

The Core Markers for GLP-1 Monitoring

Not all testing panels are equally useful for GLP-1 users. Below are the categories that matter most and why.

Metabolic Markers

HbA1c is the three-month glucose average, and the single most useful metabolic marker for GLP-1 monitoring. If your HbA1c was elevated at baseline and drops at 3 months, that is direct confirmation of metabolic benefit. If you are already on diabetes medication and HbA1c drops significantly, it may flag a need to adjust that medication with your GP.

Fasting glucose gives a point-in-time reading and is useful alongside HbA1c.

Lipid Panel

GLP-1 receptor agonists improve lipid profiles in the majority of users, typically reducing triglycerides and LDL cholesterol, and increasing HDL. Without a baseline and a follow-up, you cannot verify this is happening.

A full lipid panel should include total cholesterol, LDL, HDL, triglycerides, and non-HDL cholesterol. Non-HDL is increasingly considered more clinically useful than LDL alone as it captures all atherogenic lipoproteins.

Liver Function

Liver enzymes, particularly ALT and AST, are the standard markers for liver health. GLP-1 medications have documented benefit for non-alcoholic fatty liver disease (now termed MASLD), with clinical trials showing significant reductions in liver fat. A baseline ALT and a repeat at 6 months will tell you whether this is happening in your case.

For more on the liver angle, see /guides/glp1-liver-health-monitoring.

Kidney Function

eGFR (estimated glomerular filtration rate) and creatinine are the standard markers for kidney function. On GLP-1, nausea-driven reduced fluid intake can cause subclinical dehydration, which may transiently affect kidney markers. This is usually mild and reversible, but a baseline eGFR gives you something to compare if kidney markers come back flagged.

For a detailed breakdown of kidney markers, see /guides/glp1-kidney-function-monitoring.

Thyroid

TSH (thyroid-stimulating hormone) is the standard first-line thyroid marker. The theoretical concern about GLP-1 and thyroid C-cell tumours, based on rodent data, has not been confirmed in human trials at the doses used clinically. Monitoring provides reassurance rather than reflecting a confirmed risk.

A baseline TSH before starting and a repeat at 12 months is a reasonable standard. For a detailed look at the thyroid evidence, see /guides/glp1-thyroid-monitoring-uk.

Full Blood Count

Caloric restriction, which typically accompanies significant appetite suppression on GLP-1, can lead to reduced iron, B12, and folate intake if dietary quality drops. A full blood count including haemoglobin gives an early signal if nutritional anaemia is developing. This matters more on long-term use than in the first few months.

The DNA Health Testing Angle

AlphaBiolabs' DNA testing background is relevant for a specific subset of GLP-1 users: those with family history of thyroid cancer, particularly medullary thyroid carcinoma (MTC).

Hereditary MTC is associated with RET proto-oncogene mutations. The theoretical concern about GLP-1 and thyroid C-cell tumours, though unconfirmed in humans, makes genetic context relevant for this group. If you have a family history of MTC or multiple endocrine neoplasia type 2 (MEN2), genetic testing and specialist review before starting GLP-1 is appropriate.

AlphaBiolabs offers genetic health panels. This is not standard monitoring for the average GLP-1 user, but it is worth knowing the testing is available for those with relevant family history.

How the Testing Process Works

AlphaBiolabs health panels are ordered online. A kit is posted to your home address. Blood collection is typically via finger-prick, though collection methods vary by panel. Check the specific kit requirements before ordering.

The sample is returned by prepaid post to their UK laboratory. Results are delivered to your online account, usually within 2 to 5 working days of receipt. Reference ranges are included alongside your results.

AlphaBiolabs does not provide clinical interpretation beyond reference range flags. If a result comes back outside the normal range, the appropriate next step is your GP or prescriber, not a callback from the testing service. This is standard for at-home testing services and worth understanding before ordering.

How AlphaBiolabs Compares to Other UK Testing Options

Several private testing services cover the same markers relevant to GLP-1 monitoring. The main options in the UK market include Lola Health, Medichecks, Forth, and AlphaBiolabs.

Lola Health positions itself as a longevity-focused testing platform with biomarker tracking over time and some interpretation support. For a full review of what they offer GLP-1 users, see /guides/lola-health-review-glp1.

Medichecks is one of the longest-established UK private testing services, with a broad panel catalogue and GP-reviewed results on higher-tier panels.

AlphaBiolabs differentiates on laboratory accreditation credibility (UKAS) and the ability to combine health testing with DNA or other specialist testing in the same service. For users who want a single accredited lab for all their health testing needs, that has appeal.

The choice between services often comes down to which panels are currently available and what the cost comparison looks like at the time of ordering. Panel offerings and pricing change, so check current options before committing.

Recommended Testing Schedule for GLP-1 Users

For a full protocol with specific marker recommendations and timing, see /guides/glp1-blood-test-panel-uk and /guides/glp1-monitoring-protocol.

The summary version:

Before starting GLP-1: Full metabolic panel: HbA1c, fasting glucose, full lipid panel, liver function (ALT, AST, GGT), kidney function (eGFR, creatinine), TSH, full blood count. This is your baseline. Record it. Everything that follows gets compared to this.

At 3 months: HbA1c, kidney function, liver enzymes. If nausea has been significant and fluid intake reduced, kidney markers are particularly worth checking.

At 6 months: Full panel repeat. Metabolic changes from GLP-1 are typically visible in lipids and liver enzymes by this point. A direct comparison to baseline tells the story clearly.

Annually thereafter: Full panel. Long-term GLP-1 use is increasingly supported by the evidence, particularly for cardiovascular risk reduction. Annual comprehensive monitoring reflects that commitment.

Who AlphaBiolabs Health Testing Is For

AlphaBiolabs health testing suits GLP-1 users who:

• Want UKAS-accredited laboratory testing
• Are interested in combining health panel testing with DNA or other specialist tests in a single service
• Need baseline and follow-up panels that their private prescriber does not include
• Prefer at-home collection with postal return over phlebotomy clinic appointments

It suits GLP-1 users less well if you want clinical interpretation built into the service, longitudinal tracking with trend visualisation, or nurse-collected samples at home. For those requirements, services like Lola Health or Epic Life may be a better fit.

The Bottom Line

AlphaBiolabs is a credible UK testing option for GLP-1 users who want UKAS-accredited bloodwork without a clinic appointment. The markers relevant to GLP-1 monitoring (metabolic, liver, kidney, lipid, thyroid) are available through their health panels.

The value of testing is not in the single result. It is in the comparison. Baseline versus 3 months versus 6 months tells a story that weight tracking alone never can. Whether you use AlphaBiolabs, Lola Health, Medichecks, or another service matters less than doing the testing consistently and using the results to inform your care.

If you are paying privately for GLP-1 and not running structured bloodwork, you are missing the most useful data available to you.